These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8835890)

  • 1. Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole.
    Goenka MK; Kochhar R; Chakrabarti A; Kumar A; Gupta O; Talwar P; Mehta SK
    J Clin Gastroenterol; 1996 Jul; 23(1):7-10. PubMed ID: 8835890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
    Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
    Misra SC; Dasarathy S; Sharma MP
    Aliment Pharmacol Ther; 1993 Aug; 7(4):443-9. PubMed ID: 8218758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
    Howden CW; Jones DB; Burget DW; Hunt RH
    Gut; 1986 Sep; 27(9):1058-61. PubMed ID: 3758819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease.
    Delle Fave G; Annibale B; Franceschi M; Quatrini M; Cassetta MR; Torsoli A
    Aliment Pharmacol Ther; 1992 Aug; 6(4):469-78. PubMed ID: 1420739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.
    Thorens J; Froehlich F; Schwizer W; Saraga E; Bille J; Gyr K; Duroux P; Nicolet M; Pignatelli B; Blum AL; Gonvers JJ; Fried M
    Gut; 1996 Jul; 39(1):54-9. PubMed ID: 8881809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
    Maculotti L; Pradella P
    Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom relief and duodenal ulcer healing with omeprazole or cimetidine. Opus (Omeprazole Peptic Ulcer Study) Research Group.
    Crowe JP; Wilkinson SP; Bate CM; Willoughby CP; Peers EM; Richardson PD
    Aliment Pharmacol Ther; 1989 Feb; 3(1):83-91. PubMed ID: 2491460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer.
    Lee FI; Booth SN; Cochran KM; Crowe J; Dickinson RJ; Kennedy NP; Cottrell J; Mann SG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):505-12. PubMed ID: 2518864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
    Rakov AL; Makarov IuS; Gorbakov VV; Mironenko DA; Golochalova TV
    Voen Med Zh; 2001 Sep; 322(9):54-8. PubMed ID: 11668793
    [No Abstract]   [Full Text] [Related]  

  • 15. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.
    Khoshbaten M; Fattahi E; Naderi N; Khaleghian F; Rezailashkajani M
    BMC Gastroenterol; 2006 Jan; 6():2. PubMed ID: 16403233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial.
    Lauritsen K; Rune SJ; Bytzer P; Kelbaek H; Jensen KG; Rask-Madsen J; Bendtsen F; Linde J; Højlund M; Andersen HH
    N Engl J Med; 1985 Apr; 312(15):958-61. PubMed ID: 3883182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
    Hartmann H; Fölsch UR
    Digestion; 1988; 39(3):156-61. PubMed ID: 3061859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine.
    Sikiric P; Rotkvic I; Mise S; Petek M; Rucman R; Seiwerth S; Zjacic-Rotkvic V; Duvnjak M; Jagic V; Suchanek E
    Dig Dis Sci; 1991 Jul; 36(7):905-10. PubMed ID: 2070703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.